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 Consumers from the developed world are now turning to emerging markets to 
seek and secure health services. Driven by ever-increasing costs and rationing of health 
care, these patients find physicians trained Western institutions and internationally 
accredited hospitals offering state-of-the-art amenities awaiting at the destination of 
their medical meccas. Health care costs in the United States are inflated by disparate 
labor compensation, intrusive third party involvement, abundant cross-subsidies, and 
excessive regulation. Patients in nations with single-payer health systems like the 
United Kingdom and Denmark see daunting queues standing between them and 
needed health care. Private hospitals in countries like Thailand, India, Singapore, Costa 
Rica, and Columbia, specializing in highly tradable procedures, have flattened the 
medical world, competing on a cost basis vying for the business of Western patients. 
Part I of this paper presents an over view of the phenomenon of medical tourism, 
discussing its main drivers and industry characteristics, part II takes a deeper look into 
the economic effects of trade in health services, both on exporting and importing 
countries, and part III discusses the regulatory frameworks in the United States that 









Part I: The Phenomenon of Medical Tourism 
 Uninsured American citizens in need of vital medical procedures are often faced 
with exorbitantly high costs of medical care. These costs are inflated by comparatively 
high labor costs, intrusive third party (government and insurance companies) 
involvement, lack of price transparency, cross subsidization, and industry regulation 
(Catteneo, 2009; Herrick, 2007; Turner, 2007). An invasive heart procedure, such as a 
mitral valve replacement, with a subsequent hospital stay and all associated fees can 
cost an uninsured American close to $200,000 (Lancaster, 2004). The same treatment 
performed in a foreign hospital by a foreign physician, along with post-operative care 
and travel expenses, could cost as little as five percent of the American total (Herrick, 
2007). As the cost disparity illustrated above widens and globalization continues, 
increasing numbers of patients from Western Europe, the United States, and Canada 
are choosing to forgo treatment in their homelands in exchange for cheaper or more 
timely health care offered in premier medical centers located around the world.  
  Deloitte Consulting estimated that 750,000 Americans went abroad to receive 
healthcare in 2007 and projected that this number would grow by 100% annually to 
reach over six million outpatients by 2010. Deloitte readjusted their estimates to account 
for the recessional effects in 2010, but the trend remains similar, predicting sustained 
growth at 35% annually (Deloitte, 2010). McKinsey & Company (2006), also predicted a 
large increase in worldwide medical tourism would take place in the latter half of the 
decade, estimating that the industry’s gross profit would expand from $60 billion USD in 
2006 to $100 billion USD by 2012 (Herrick, 2007). Reliable estimates, however, of the 
numbers of ‘medical tourists’ capitalizing on more cost-effective patient care abroad are 
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sometimes hard to obtain due to a lack of transparency in destination markets and a 
lack of international regulation of the industry. 
 
Why seek treatment abroad?  
 Medical tourists seek treatment abroad for two main reasons: 1) vastly disparate 
costs or 2) access to timely treatment. Patients seeking to capitalize on cost advantages 
found in emerging markets are frequently American citizens bridled by the rising costs 
of health care in the United States. Patients seeking more timely medical treatment 
often reside in countries that provide universal healthcare but lack the infrastructure and 
resources to perform all needed procedures in a timely manner, like in the United 
Kingdom or Canada. Each reason can be reconciled by well trained physicians in 
developing nations, offering readily available medical care at discounted costs. (Turner, 
2007) 
 Several countries around the world provide destinations for medical tourists, but 
most of the increasing traffic is concentrated in Southeast Asia and South America. 
Popular destination countries include India, Thailand, Singapore, Argentina, Brazil, 
Columbia, Costa Rica, and Panama among others (Arunanondchai, 2007; Gray, 2008; 
Herrick, 2007; York, 2008). Patients who seek treatment in these countries can expect 
highly trained physicians, often educated in the United States or Great Britain, and 
hospitals accredited by the Joint Commission International (JIC), an arm of the Joint 
Commission, an American non-profit organization that accredits a variety of health 
related organizations (Singh, 2008). These hospitals are staffed with highly trained 
medical staff and utilize the latest medical technologies and equipment (Turner, 2007). 
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In addition to the medical infrastructure provided in these emerging markets, many 
hospitals provide extensive hospitality services and additional amenities to medical 
tourists, such as extended stays in five-star hotels and expertly managed recovery and 
post-operative therapy periods.  
 Several hospitals in these regions have gained international recognition for their 
prowess in treating foreigners seeking alternative medical treatment. One such hospital 
is Bumrungrad International, a JIC accredited, multi-specialty hospital located in 
Bangkok, Thailand. The hospital was constructed in 1997 in accordance with United 
States hospital building and safety standards (Herrick, 2007). Staffed by nearly a 
thousand doctors, two hundred of which are U.S.-trained and board certified, and over 
seven hundred nurses, Bumrungrad International services over one-million patients 
annually, forty percent of which represent international patients, making it the largest 
single campus hospital in Southeast Asia in both categories (Boyd, 2011; Bumrungrad 
website; Simon, 2006, June, 14). Facilities at Bumrungrad include nineteen operating 
facilities (two specifically designed for cardiac procedures), four types of intensive care 
units (adult, pediatric, cardiac, and neo-natal), two heart catheterization labs, a surgical 
navigation system, and units with endoscopy, arthroscopy, and lithotripsy capabilities 
(Bumrungrad Website). 
 Apollo Hospitals Group, headquartered in Chennai, India, is another renowned 
player in the global health care services industry. Opened by Dr. Prathap C. Reddy as 
India’s first for-profit hospital in 1983, the group now operates fifty-three individual 
hospitals treating patients from around the world (Logace, 2007). To date, seven of 
Apollo’s facilities, located in Delhi, Chennai, Hyderabad, Ludhiana, Bangalore, Kolkata, 
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and Dhaka, have gained international accreditation from the Joint Commission 
International (Apollo Hospitals Group, 2010). 
 
Medical Travel Intermediaries  
  American patients interested in seeking treatment abroad face two options when 
searching for facilities and physicians. Prospective patients may personally research the 
many hubs of cross border trade of medical services. Many of the larger facilities in Asia 
including Bumrungrad International and Apollo Hospitals Group, offer interactive 
customer service websites where customers can find specific doctors and their 
credentials and information about the facilities and services offered. Patients who are 
not familiar with the industry or specific facilities abroad, however, can coordinate 
international medical travel via the services of medical travel intermediaries (Cattaneo, 
2009; Herrick, 2007; Turner, 2007). These intermediaries work much like specialized 
travel agencies. One such intermediary, MedRetreat, offers prospective patients 
choices among 183 medical procedures in seven different countries: India, Thailand, 
Malaysia, Brazil, Argentina, Turkey, and South Africa (Davidow, 2006). GlobalChoice 
Healthcare, an intermediary located in Albuquerque, New Mexico, lists a price 
comparison on their website (GlobalChoice Healthcare Website, 2011). These price 
comparisons indicate that services received abroad could cost as little as fifteen percent 
of the cost of procedures in the United States (Alsever, 2006).  Medical travel 
intermediaries often employ trained doctors and nurses to analyze treatment options, 




 Companion Global Healthcare is a medical tourism intermediary located in 
Columbia, South Carolina. The company website offers catchy slogans such as 
“because you should be focused on your health, not the details of your trip” and “just 
because you are traveling for healthcare doesn’t mean it can’t feel like a vacation,” 
blurring the lines between health care and leisure travel. The website also offers 
prospective patients with an over view of the medical tourism phenomenon, their 
provider network, former customer testimonials, and cost comparisons. The company 
also reaches out to employers, stating that their services can compensate for large 
deductibles that characterize many small business insurance plans. (Companion Global 
Healthcare, 2011). 
 
Cost Disparity  
 The great disparity of costs between the United States and other parts of the 
world exists for several reasons. A wide variety of studies and cost analyses have been 
conducted comparing specific costs for commensurate procedures between the United 
States and other areas that often service international patients. Depending on the 
country, costs can be as much as 80-90% less than equal treatment in the United 




 The Center of Medicaid and Medicare Services (CMS) calculated that Americans 
spent $2.5 trillion on health care in 2009, far more than any other country in the world 
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(CMS, 2010). Labor costs in the United States, according to some studies, account for 
over half of the total cost of medical treatment. In 2004, Fitch Ratings, a respected 
management solutions company based in New York, published results finding that 
across 215 not-for-profit hospitals in the United States, labor costs constituted 52.2% of 
total hospital patient billing (Berger, 2005). Virtually all hospital personnel, doctors 
nurses, orderlies, management, unskilled labor, require significantly more labor costs in 
the United States than in other parts of the world. The premium price on labor seen in 
the healthcare industry is determined by the same macroeconomic factors that cause 
high labor costs in other industries. These causes, however, are exacerbated in the 
health care industry because of third party involvement and other regulations.  
 
Third Party Involvement: 
 Of the $2.5 trillion spent on health care in the United States in 2009, third party 
payers (insurance, employers, and government) accounted for 71.9% of the total 
expenditures (U.S. Department of Health and Human Sciences, 2010). Markets such as 
health care, characterized by a intrusive third party involvement, often operate very 
bureaucratically and inefficiently. As a result of third party involvement, customers do 
not act like logical consumers when shopping for health services, and providers do not 
compete for business on a price basis (Herrick, 2007). Other countries, however, 
especially those who have become leaders in cross border trade of health services, 
often have a much lower proportion of third party payers. Domestic patients in India, 
Mexico, Thailand, and Singapore all pay in excess of 50% of total health expenditures 
(WHO, 2008). Health care markets in these countries operate much more competitively, 
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based largely on price considerations. This environment of competition allows for lower 
prices throughout the industry. Elective medical services, including plastic surgery and 
non medical vision corrections, for which patients usually pay for out of pocket, are 
much more competitive than procedures that endure high third party involvement in the 
United States (Herrick, 2007). 
 
Lack of Price Transparency 
 When visiting a hospital or considering a medical procedure in the United States, 
prospective patients often cannot know the exact price of health services prior to 
treatment. Health care providers are resistant to price transparency for several reasons: 
1) health care costs and payment systems are not standardized, 2) insurers do not want 
to disclose their negotiated prices, and 3) costs often vary widely between geographical 
regions (Kavilanz, 2009). Undisclosed health care prices bridle competition in the 
market, allowing for inflated prices. 
 
Abundant Cross-subsidies 
 The American health care industry consists of a large number of nonprofit 
general hospitals. These hospitals often subsidize procedure costs with revenues from 
other procedures. For example, a highly invasive heart surgery may bill more than it 
actually costs the hospital. The hospital then uses the excess funds to compensate for 
operations that typically lose money such as emergency care and charity care for the 





 American doctors are often subject to high malpractice risks because of the 
patient oriented legal framework in the United States. While physicians in the United 
States might face upwards of $100,000 annually, amalgamating to approximately $55.6 
billion industry wide, in malpractice insurance alone, doctors in Thailand pay an annual 
average of $5000 (Roth, 2006; Fox, 2010). Many developing countries, including 
Thailand, do not compensate patients for noneconomic damages (i.e. psychological 
pain and suffering).  
 
Quality Concerns 
 Any time a patient makes a critical decision concerning personal health, quality 
and reliability of health care are chief concerns. Though quality metrics are not uniformly 
disclosed in the international medical marketplace, several studies have been 
conducted examining key quality indicators in the large foreign hospitals that regularly 
service western patients. According to a study by Project Hope, Bumrungrad (Thailand), 
Apollo (India), and Wockhardt (India), each of which are accredited by the JIC as 
meeting international standards for hospital facilities and surgical accommodations, 
experiences less than a one percent mortality rate in coronary artery bypass graft 
(CABG) procedures (Milstein, 2007). The same study finds that the average mortality 
rate for the same procedure in high volume hospitals in California is 2.91%. Mortality 
rates for CABG patients at the most renowned American hospitals, such as Cleveland 
Clinic and Johns Hopkins, are comparable to the best international hospitals (Herrick, 
2007; Milstein, 2007).  
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 Hospitals in the global market seek to distance themselves from the negative 
connotations associated with third world health care. Top international hospitals employ 
highly trained physicians, many of whom received training from renowned medical 
schools in the West at facilities like Johns Hopkins University, the University of 
Birmingham, and the University of London (Turner, 2007). Additionally, many medical 
facilities in developing countries have secured partnerships with reputed American 
medical centers. Wokhardt Hospital in India is associated with Harvard Medical School, 
and Apollo Hospitals Group partners with Johns Hopkins Medicine International (Turner, 
2007). Duke University has partnered with the National University of Singapore and the 
Singapore government to operate a top quality medical school in the country’s capital 
that opened in 2007 and will graduate its first class in 2011 (Gallaher, 2009).  
 
Part II: Economic Effect of Cross-border Trade in Health Services 
 Trade in health care is nothing new. Patients from around the world have long 
taken journeys to secure health care that fits their needs. What is new, however, is the 
direction of trade. Traditionally, developed countries like the United States, Great Britain 
and other countries in Western Europe with strong medical capabilities have exported 
health services to underdeveloped countries. Elite medical facilities in the United States 
and other developed countries such as the Cleveland Clinic, the Mayo Clinic, 
Massachusetts General Hospital and others focused efforts towards expanding their 
international clientele in the 1980s and 1990s (Turner, 2007; Weber, 1998). Lured by 
the promise of top quality health care, wealthy patients from the Middle East, South 
America, and other areas of the underdeveloped world capitalized on treatments offered 
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in the United States and Western Europe. In the last ten years, however, trade has 
reversed. Patients from the developed world are now turning to underdeveloped areas, 
seeking quality health care at discounted costs, able to be provided on a nearly 
immediate basis. Economists are only beginning to study the phenomenon of the new 
model of cross-border trade in health services. 
 
Types of Trade in Health Services 
 The phenomenon of cross border health sector trade can refer to a variety of 
different market interactions. Economists have broken trade in health services into four 
separate modes to describe each interaction more narrowly (Cattaneo, 2009). Although 
each mode is related, each is different and offers a unique dynamic between health 
care markets. This paper will focus on mode two, yet it is important for readers to 
recognize the nature and potential benefits of modes one, three, and four as well. 
Mode 1: Tele-medicine 
Although it remains underdeveloped in several ways, tele-medicine is a prominent mode 
of health service trade. As Singh and Wachter (2008) describe, technology now allows 
the remote electronic outsourcing of medical services from diagnostics to direct care. 
Mode 2: “Medical Tourism” 
Medical tourism refers to the treatment of patients in foreign markets. The newly popular 
model of medical tourism sees patients from rich countries such as the United States, 
Great Britain, etc often travel to developing countries like India, Singapore, or Thailand 
to receive medical attention. As discussed in part I, medical facilities and practitioners in 
these countries hold significant international certification,    
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Mode 3: Foreign commercial participation in domestic health care 
While economies of both developing and developed countries stand to benefit from 
foreign participation in their domestic health care structures, regulatory environments 
often disallow foreign participation on a large scale. Foreign participation potentially 
offers new resources, fosters competition, and encourages technological advances in 
domestic markets. 
Mode 4: Physical presence of foreign medical personnel in domestic markets 
In cases where a market suffers from supply shortages, medical personnel can be 
imported into the country to alleviate demand stresses, leading to reduced training 
costs, increased flexibility, and greater access to health care for consumers.   
(Cattaneo, 2009; Herman, 2009) 
 
Tele-medicine 
 Much like other outsourcing trends seen in the business world, disparate labor 
costs, technological advances, and increased communication have created a 
sustainable venue for cross-border trade in electronic-based health services. Digitized 
medical records, technologically advanced healthcare facilities, and additional 
infrastructure allow for electronic delivery of services traditionally offered only in a face 
to face setting including clinical (e.g., specialist consultation), diagnostic (e.g. 
teleradiology), or information distribution (Singh, 2008). 
 The most prevalent form of telemedicine is teleradiology, the practice of 
outsourcing diagnostic services to foreign countries to be read by licensed radiologists 
(Singh, 2008).  According to some studies, over 300 hospitals in the United States and 
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over two thirds of radiology practices are regularly engaged teleradiology (Wachter, 
2006). Much of the compulsion to outsource radiological services stems from cost 
considerations. Similar to medical tourism, costs of domestic radiology services are 
inflated by labor costs, third party involvement and a lack of competition (Singh, 2006). 
Another significant reason for teleradiology is it’s accessibility. For example, when a 
patient is admitted into the emergency room after an early morning car wreck, the 
hospital may take X-rays or other diagnostic images on site, but send them to a hospital 
in India for immediate review. In this scenario, an Indian radiologist will read the images 
during normal working hours and send his or her findings back to the hospital so the 
patient can be prepped for an emergency surgery as  soon as a doctor arrives to the 
facility. This strategy relieves the need or around the clock on-call services, thus, saving 
costs and streamlining diagnostic procedures. 
 Several intermediaries link imaging technicians and equipment with radiologists 
around the world. VRad (Virtual Radiology), is a teleradiology intermediary partnered 
with over one-hundred radiologists around the globe (vRad, 2011). VRad, now one of 
the largest teleradiology companies in the United States, recently bought NightHawk 
Radiologists, another intermediary in the industry. Before the merger, the average 
NightHawk Radiologist held thirty-eight state licenses and had staff privileges in about 
four hundred hospitals. The firm employs thirty five people whose sole purpose is 
overseeing the licensure and credentials of radiologists in their network (Wachter, 2006) 
 Although teleradiology is the most prevalent form of telemedicine, a few 
innovative firms and hospitals are taking the practice to new boundaries. Advanced ICU, 
a firm based in St. Louis, Missouri, contracts with several hospitals in midwest to 
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coordinate and operate remote intensive care units, bringing “scarce critical expertise to 
ICU patients via telemedicine” (Advanced ICU website, 2011). Remote intensive care 
allows for intensivists, with the aid of cameras, electronically relayed sensory details, 
and other communication tools such as online decision support and adverse event 
notification, to monitor several patients in multiple hospitals from a central location 
(Henkel, 2006). Studies have shown promising results from the practice of remote 
intensive care practices. One early study conducted in 2004 showed that eICUs 
resulted in a 27% reduction of severity-adjusted hospital mortality, a 17% drop in length 
of ICU duration, and an average savings of $2,150 per patient (Breslow, 2004). 
 
Medical Tourism 
 Medical tourism, as is overviewed in part I, consists of the physical treatment of 
domestic patients in a foreign country. The most common model sees rich countries 
such as the United States or Great Britain importing services from poor countries, 
though other models exist as well. Unlike telemedicine, all services, except for post-
operative follow up care, are rendered in the destination country, thus, medical tourism 
represents more of a traditional trade model than telemedicine’s outsourcing model. The 
economic effects are similar, but not the same. 
 
Benefits to Medical Tourism 
 The phenomenon of mode two cross-border trade in health services is largely 
market driven, shaped by multiple tensions found in medical, economic, political, and 
social forces. Many rich countries, namely the United States, find themselves in a 
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position of ever-increasing health care costs caused be several factors discussed in part 
I. Other rich countries such as the United Kingdom, Denmark, Canada, and other 
single-payer model countries are experiencing health service imports because of 
political structures that cause capacity-based health care rationing. Section II will 
examine these forces, especially the economic drivers, more closely as well as the long 
term effects that they could imply. 
  
Cost Reduction 
 Drivers behind cost disparities were overviewed in Part I. The labor costs, third 
party involvement, price secrecy, cross-subsidies, malpractice risk, and lack of 
specialization found abundantly in the American health system lead to health care 
prices far greater than seen in many developing countries. Table 1 below details the 
difference in costs of several common medical procedures between the United States, 
Singapore, Thailand, and India. Table 2 shows the percentage differences compared to 
the United States prices. 
 
 
Table 1: Comparative costs of surgical procedures 
 
Procedure Cost in USD 
 USA Singapore Thailand India 
Heart Bypass 130000 18500 11000 10000 
Heart Valve Replacement 160000 12500 10000 9000 
Angioplasty 57000 13000 13000 11000 
Hip Replacement 43000 12000 12000 9000 
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Procedure Cost in USD 
Hysterectomy 20000 6000 4500 3000 
Knee Replacement 40000 13000 10000 8500 
Spinal Fusion 62000 9000 7000 5500 
 
Source: Cattaneo (2009), based on Einhorn (2008) and author’s calculation. 
 
 
Table 2: Percent disparity compared to United States 
 
Procedure Cost compared to the USA 
Heart Bypass 14.20% 8.50% 7.70% 
Heart Valve Replacement 7.80% 6.30% 5.60% 
Angioplasty 22.80% 22.80% 19.30% 
Hip Replacement 27.90% 27.90% 20.90% 
Hysterectomy 30% 22.50% 15% 
Knee Replacement 32.50% 25% 21.30% 
Spinal Fusion 14.50% 11.30% 8.90% 
 
Source: Cattaneo (2009), based on Einhorn (2008) and author’s calculation. 
 
  
 The cost saving potential for the United States for mode 2 trade in health 
services is significant. According to a study conducted in 2004 examining key price and 
demand indicators, the American healthcare industry would save approximately $1.4 
billion (USD) annually if only ten percent of patients were to go abroad for a limited set 
of fifteen highly tradable, low risk treatments (Mattoo and Rathindran, 2006). In order to 
diagnose these fifteen procedures, Mattoo et al partnered with the World Bank’s Health 
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Services Department to derive six qualifications that a procedure must meet to be 
considered highly tradable. The criteria are as follows: 
1) The surgery constitutes treatment for a non-acute condition, meaning the nature of 
the condition does not require immediate medical attention 
2) The patient is able to travel long distances without significant pain or debilitating 
inconvenience 
3) The surgery is fairly simple and commonly performed with minimal post-operative 
complications 
4) The surgery requires minimal on sight follow up visits 
5) The surgery generates minimal pathology and laboratory reports 
6) The surgery results in minimal post-procedural immobility, allowing patients to return 
to their home countries in a timely fashion. 
 
Trade in Associated Services  
 Medical tourism also requires the trade of significant ancillary services because 
all activities associated with a destination medical trip are included. This includes 
paramedical services, but also transportation, housing accommodations, and other 
services often associated with traditional tourism (Cattaneo, 2009). Because physicians 
found in many hospitals specializing in treatment of medical tourists have been 
educated in top American medical programs, trade in medical education also 
accompanies medical tourism (Herrick, 2007). Mode two trade in health services also 
requires the cross-border trade of goods associated with health care including, but not 
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limited to health care equipment, pharmaceuticals, and medical waste products. 
(Cattaneo, 2009) 
 
Increased Competition in the Health Industry  
 As discussed briefly in part one, medical travel liberalizes the healthcare market, 
leading to greatly increased competition among countries, facilities, and providers. The 
destruction of national barriers opens up the world market to global competition in 
health services. In an environment where consumers can freely act as rational 
customers, competitive advantage and specialization becomes the driving force behind 
consumer movement (Turner, 2007).  
 Most of the well known destination hospitals including Bumrungrad International 
and Apollo Hospitals Group make efforts to specialize in surgeries and procedures often 
sought out by medical tourists. Well known medical tourism destination hospitals invest 
significant resources into these programs. For example, Bumrungrad International 
invested significant resources into two state-of-the-art cardiac surgery theaters 
(Bumrungrad website). Hospitals in Australia often specialize not only in cancer 
treatment, but treatment of specific types of cancer (Chu, 2005).  
 
What makes a nation a good market for medical tourism? 
 A profitable atmosphere for health service export is bred in ways similar to other 
services. The right mix of national factor endowments, development strategies, demand 
conditions, and related industries leads to export potential. Countries discussed in this 
paper usually have similar make-ups in these categories. According to a paper 
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 Countries specializing in medical outsourcing possess similar input factors 
(Harryono, 2006). Firstly, physical infrastructure including hospitals, medical research 
centers, and accommodating facilities are necessary to breed an export market for 
health services. Human capital is also an important factor. Countries like Thailand and 
India have strong medical education programs as well as programs for aspiring 
physicians to receive medical training in developed countries like the United States 
(Herrick, 2007). Many countries that take advantage of medical tourism also possess 
well-developed hospitality industries. Countries like Thailand and Singapore have strong 
tourism industries independent of medical services. Bangkok, capital of Thailand and 
home of Bumrungrad International Hospital, has many five-star hotels, a bustling 
restaurant industry, and other well established tourist accommodations.  
 
National Economic Development Opportunities 
 National political and economic strategies and atmospheres also serve to breed 
increased trade activities in health sectors. As a result of economic crises facing much 
of the undeveloped world in the 1990s, national health care markets collapsed in many 
Asian and South American countries. Amidst the downturn, private hospitals in Thailand 
began seeking patients from international markets. The dire Thai economy led to rapid 
currency devaluation, rampant unemployment, and hellacious market behaviors. People 
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across Thailand lost their savings as importing medical equipment became 
unsustainably expensive and local citizens could no longer afford to purchase private 
health care (Chantarapitak, 2006). The economic conditions in Thailand, especially the 
drastically devalued baht, provided the perfect atmosphere for Bumrungrad International 
Hospital to make a significant step into the global market place (Turner, 2007). 
Bumrungrad quickly attracted a substantial international clientele, as it became the first 
Joint Commission International accredited hospital in 2002, promising first-world quality 
health care at relatively inexpensive prices as Thailand became one of the hottest 
destinations for medical tourists.  
 Health care stakeholders around the world noticed as Thailand’s medical imports 
took flight. Underdeveloped areas in similar economic situations--low wages, low 
corporate taxes, inexpensive property, negligible malpractice risk, favorable currency 
exchange rates, and able medical capital--recognized the opportunities before them as 
the proliferation of cost-based medical tourism became a living phenomenon (Turner, 
2007). 
   Many governments in medical tourism hotbeds view cost-based medical tourism 
as a vehicle for economic and social development. The integration of health care and 
tourism industries offers many developing countries a unique opportunity for economic 
diversification, attracting foreign investment, promoting job growth, and capitalizing on 
comparative advantages based on factor endowments and demand conditions 
(Cattaneo, 2009). 
 In recent years, Singapore has developed the most cohesive in institutionalized 
approach to bolstering health care export activities. Rather than relying on American 
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third party intermediaries as discussed in part 1, the Singaporean government promotes 
medical travel to the country via a public-private partnership with Singapore Medicine 
(Turner, 2007). Prospective patients are able to find hospitals, patient centers, and 
specific specialists on the Singapore Medicine website, providing easy access to all 
major health providers in Singapore. The governments strategy has paid off as 
international patients finding treatment in Singapore increased from 150,000 in 2001 to 
374,000 in 2005  and is projected to exceed 1 million visits by 2012 (Yap, 2006a). 
 Other countries have mirrored the successes of Bumrungrad International’s 
global marketing strategies and Singapore’s focused development strategies. India’s 
government has adopted the view that care of international patients represents an 
important export. To support this cause, the government has enacted special zoning 
laws, reduction of tariffs on imported medical equipment, lower corporate taxes, and 
increased government investment in transportation and related infrastructure (Turner, 
2007). Countries who are not yet major players in the health services export market, 
namely Vietnam, South Korea, and Taiwan, are also examining ways to attract 
increased numbers of international patients (Catteneo, 2009). 
 The proliferation of export trade in health services in developing countries 
certainly leads to many economic advantages, but the disadvantages associated with 
stratifying the availability of health care, weighted heavily towards international patients 
and socioeconomic elites should be a major concern for medical tourism hot spots.  
“Crowding out” of the market should be a concern for nations looking to bolster medical 
tourism within their borders. Drawn by low costs and accessibility of health care 
facilitated by the national strategies discussed above, increased international health 
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travelers will lead a rise in prices over the long run, a progression that will make health 
care more inaccessible for local patients (Turner, 2007). Thailand has especially 
worrisome concerns about redistribution of health care associated with increased health 
care exports. By not participating in national health insurance schemes, private 
hospitals in Thailand generate more revenue per patient, allowing them to attract more 
medical personnel by offering higher compensation (Arunanondchai, 2007). Thus, the 
country’s best physicians are diverted away from public health facilities 
(Wibulpolprasert, 2008). This internal “brain drain” diverts between 240 and 700 Thai 
physicians away from the public sector for every additional 100,000 medical tourists that 
visit the country (Pannarunothai, 2004; Wibulpolprasert, 2008).  
 
Demand Conditions 
 International demand for health care in the developing world is enhanced by a 
number of factors. Beyond the infrastructure and educational facilities that make an 
international level of health care possible, demand can also be boosted by expatriates 
in the region and established tourism trends.  
 Outsourcing and expatriate trends have shifted heavily towards the developing 
world including many of the same countries who have seen increased medical tourism 
(Terry, 2007).  Countries like Thailand, China, Taiwan, India, and Singapore enjoy 
substantial numbers of expatriates from the developed world demanding first-world level 
health care (Turner, 2007). An established flow of international tourists also leads to 
increased trade in health services for developing countries. Southeast Asia enjoys the 
travel of many western tourists looking for an exotic vacation. Top countries include 
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Thailand, Singapore, and Malaysia (Harryono, 2006). Thailand’s national inbound 
tourism continues to rise at an astonishing rate, realizing annual growth of over 12% in 
2010 as total national arrivals reached 13.3 million tourists (UNWTO, 2011). Many 
countries in South America and the Caribbean region see increased medical tourism as 
a mirror of traditional tourism patterns. For instance, tourist rich countries like Costa 
Rica, known for its quality dental work, and Brazil, known for cut-rate plastic surgery 
have seen increased medically-based travel as general tourism increases (Herrick, 
2007).    
 
Related and Supporting Industries 
 Well developed supporting industries allow for better experiences for 
international patients. In Thailand, Singapore, and India, patients often arrange to stay 
in five-star hotels or other living facilities during recovery. Thriving restaurants and 
shopping also attract patients looking to blend the lines between traditional tourism and 
medically-based travel. Models such as Singapore’s institutionalized medical brokerage, 
serving as a travel agency offering both medical and leisure accommodations, 
streamline the process of international medical travel (Turner, 2007).  
 
Insurance Companies and Medical Tourism 
Recognizing the cost-saving potentials found in the import of medical services, 
insurance providers in the United States have also taken note of the globalization of the 
health care industry. Traditionally, the vast majority of insurers in the United States do 
not cover services rendered by foreign providers, but large insurers are considering 
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ways to take advantage of low cost health care found in developing countries. Mercer 
Consulting Group has been assisting many Fortune 500 companies as they explore 
insurance options allowing foreign travel since 2005 (Herrick, 2007). Arnold Milstein, 
chief physician Mercer’s Health and Benefits division, stated in 2005 that “many 
companies see [medical tourism] is a natural extension of the competition they have 
faced in other aspects of their business” (Fraser, 2006). 
 Insurance plans that cover foreign health care services are already sparsely 
offered in the United States. BlueShield of California institutionalized “Access Baja” in 
2000, a program providing coverage for certain procedures performed in Mexico. 
Originally designed to provide Mexican Nationals who commute to Southern California 
for work with affordable health care in their domestic country, the program garnered 
40,000 participants by 2005, many of whom were American citizens (Herrick, 2007). 
Insurance premiums under the Access Baja plan as well as similar plans now offered by 
HealthNet and SIMNSA are about 40% less than the cost of alternative plans offered by 
BlueShield of California (Cortez, 2010). In February 2007, BlueCross BlueShield of 
South Carolina added Bumrungrad International Hospital to its network, though no 
financial incentives to take advantage of the Thai facility were offered. BlueCross 
BlueShield of South Carolina also created a medical tourism intermediary, Companion 
Global Healthcare, as a subsidiary to arrange international medical travel that may or 
may not be covered by BlueCross BlueShield (Fraser, 2006; BlueCross BlueShield of 
South Carolina Website).  
 Some governmental entities in the United States have considered offering 
international health care plans to state employees. State legislatures in West Virginia 
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and Colorado considered legislation that would have offered travel reimbursement and 
a cash rebate for state employees who seek treatment in Joint Commission 
International accredited hospitals (Terry, 2007). Each bill, however, was rejected upon 
regulatory grounds (Cohen, 2010). 
 
Barriers to Coverage of international health care  
 In their 2006 article, Additya Mattoo and Randeep Rathindran argue that health 
insurance programs that do not accommodate international health excursions are 
discriminatory in nature, disallowing consumers to take advantage of health providers in 
the international market to reduce premiums and deductibles. They argue that the basic 
economic, institutional, and intellectual infrastructures are already well in place to 
support large scale medical tourism, leading to cost savings and greater access to 
health care. Mattoo and Rathindran identify four reasons that American insurance 
providers are hesitant to adopt coverage of international treatments:  
1) quality concerns and asymmetric malpractice laws  
2)  cost of monitoring health care consumption abroad 
3)  increased costs for the public health care system 
4)  distorted incentives in oligopolist markets. 
 Quality assurance should be a major concern for any health insurer. International 
accreditation measures seen in a number of foreign medical facilities, the strength of 
foreign physicians, and dedication among health care exporters, however, should calm 
the fears of American insurers. Malpractice policies and other legal framework 
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asymmetries, which will be discussed at length in part III, present a more ominous 
concern. 
 Faced with increased overhead expenditures, possible overconsumption, and the 
financial uncertainty of the international market, insurers worry that the coverage of 
foreign treatments will greatly increase their costs. Collaborating with foreign insurers 
and institutionalizing agile oversight processes, however, could mitigate these concerns 
(Warner, 1998). 
 In the United States, heavily cross-subsidized medical procedures increase the 
income of the public health system. “Profitable” patients (e.g. patients receiving capital 
intensive, pre-meditated procedures usually covered by a patient’s existing insurance) 
compensate for losses incurred by emergency care and other nonprofitable forms of 
care. If a large portion of these profitable procedures move offshore, hospitals and 
public health systems will have no way to cover the unprofitable procedures that cannot 
be moved abroad. Similarly, economies of scale exploited in large volumes of profitable 
procedures may be lost as services move to low-cost regions, lowering the prices for 
patients able to travel, but effectively raising prices for those unable to travel. Mattoo 
and Rathindran vaguely propose the institutionalization of tax systems to compensate 
for lost revenues, but also assuring that medical tourists remain better off. 
 Mattoo and Rathindran argue that American insurers resist the adoption of 
international policies because of distorted incentives caused by the oligopolist nature of 
the health care system in the United States. In a noncompetitive market, insurers are 
not incentivized to reduce costs for consumers. The increased competition that would 
accompany the promotion of international health travel would remove insurers from the 
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protected oligopoly of the American health care system and lower prices for American 
consumers.     
 
Part III: Regulatory Framework 
 
 The health care industry in the United States experiences extensive regulation by 
both government institutions and inter-industry regulatory bodies. The current regulatory 
framework was erected largely in the name of consumer protection and ranges from 
physician licensure procedures to approval of pharmaceuticals and medical procedures.  
 
Regulatory Framework in the United States  
 The two main federal health care oversight agencies are 1) the United States 
Public Health Service, which is comprised of the Food and Drug Administration, Center 
for Disease Control and Prevention, Agency of Health Care Research and Quality, and 
other boards, and 2) the National Institutes of Health which conducts substantial health 
related research.   The passage of the Patient Protection and Affordable Care Act in 
2010 extended the federal government’s involvement in health care to unprecedented 
levels, mandating that all citizens must purchase health insurance through federal, 
employer, or private means and that insurance companies cannot deny prospective 
customers based on preexisting conditions (PPACA, 2010). 
 State governments have a more fluid role in health care regulation. In addition to 
maintaining their own health departments, states regulate insurance markets, physician 
licensure, referral practices, collaborative frameworks and other facets of the medical 
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industry. Regulation varies between states and often reflects the overall political 
environment of the state and its historical legislative tendencies. 
 The health care industry is characterized by substantial internal regulation. 
Boards like the American Medical Association and state medical boards offer 
certification for qualified physicians. Boards such as the Joint Commission on the 
Accreditation of Hospital Organizations offer inspection and certification of care giving 
facilities. 
 The regulation of the health care industry has often been a controversial topic of 
debate among industry stakeholders, politicians, and external analysts. The Patient 
Protection and Affordable Care Act sparked fierce debate about the role of the federal 
government in the health care industry. Its impact on the industry remains to be seen, 
but it is reasonable to expect overall federal health care spending to increase and 
capacity based rationing of health services to become a factor in caregiving. In 2004, 
the Cato Institute, a conservative think tank and research firm, published a report 
claiming that the American health care realizes benefits of $170 billion, but costs the 
economy $340 billion (Conover, 2004).  
 The extensive regulation of the health care industry in the United States leads to 
most of the cost drivers discussed in part I, resulting in domestic health care that is 
drastically more expensive than foreign options. The industry experiences inflated labor 
costs due to an inefficient compensation structure enforced by payment regulations that 
lead to economic distortions for both physicians and insurance companies. Third party 
involvement leads to several cost increases in a variety of ways including cross-
subsidies, malpractice risk, and oligopolistic competition.  
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 Inflated costs, as discussed throughout this paper, drive many patients from the 
developed world to seek care in other countries. The regulatory framework itself, indeed 
a large factor in exorbitant American healthcare costs, however, limits this phenomenon 
to uninsured patients forced to seek treatment in the competitive international market. 
Governmental regulations, private regulations, and insurance practices fail to facilitate 
the possibility of increased trade in health services. An effort to restructure pertinent 
policies and regulations while preserving patient protection to allow or encourage 
increased medically based travel could save the United States’ health care system 
billions of dollars and increase the accessibility of quality health care (Mattoo, 2006).  
 
Obstacles to Increased Medical Tourism 
 Most states have policies requiring that physicians be licensed in the state where 
they render treatments to patients, ostensibly preventing medical tasks performed by 
providers living in other states or countries from being covered by insurance (Herrick, 
2007). Furthermore, foreign physicians who do not hold licensure in the United States 
cannot order tests, initiate therapies, or prescribe pharmaceuticals that may be 
beneficial in the diagnostic or follow-up stages of care to patients living in America. 
Additionally, states prohibit physician consultations performed via telephone, internet or 
other communication medium prior to an initial face to face meeting (Herrick, 2007).  
 Federal and state regulations also restrict collaborative efforts among health care 
providers. Restrictions on patient referrals, first enacted with the “Stark Law” in 1992, 
prohibit physicians from referring patients for treatment to clinics or other care giving 
facilities in which he holds a financial interest. Sponsored by United States 
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Representative Pete Stark of California, the Omnibus Budget Reconciliation Act of 1989 
(OBRA) outlined these referral regulations to prevent over-utilization of services 
characteristic of a captive referral system (OBRA, 1989; Leibenluft, 2011). These laws, 
rightly intended to prohibit self-interested kickbacks, also inhibit constructive 
collaboration among doctors and hospitals. Collaborative efforts between American 
physicians or facilities and international physicians, such as Harvard Medical Schools 
partnership with Wockhardt Hospital in Mumbai and Duke University Medical School’s 
venture with the University of Singapore, are often times dampened by these and other 
restrictions on collaboration (Gallaher, 2009; Turner, 2007; Herrick 2007).  
 Follow-up care is often not readily available for medical tourists once they return 
to the States. The burden of follow- up care falls to the domestic health system when 
medical tourists return to the States, but patients often have trouble locating a physician 
willing to provide follow-up care for a procedure performed abroad (Gray, 2008; Herrick, 
2007). A physician’s reluctance to provide follow-up care stems from several reasons. 
Most notably, physicians perceive providing post-operative assistance for a procedure 
performed by another provider as a liability, especially if the patient was treated abroad 
(Gray, 2008). Patients who seek treatment from foreign providers often lack insurance 
coverage, causing further reluctance for American physicians to offer follow-up care due 
to the uncertainty of financial incentive (Herrick, 2007).  
 There are also legal barriers to international health travel. Many employers have 
begun to recognize the cost saving potential of incentivizing medical tourism, but remain 
hesitant because of a few important legal conditions. Insurance sponsors must adhere 
to the regulations presented in the Employee Retirement Income Security Act (ERISA), 
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which, among other things, provides minimum standards for employee benefits 
including health insurance protection (ERISA, 1974; Purcell, 2009). Other forms of trade 
in health services, particularly Mode 1 (telemedicine), raise concerns pertaining to 
patient privacy under the Health Insurance Portability and Accountability Act (HIPAA). 
HIPAA provides privacy protection of electronic patient records and establishes national 
standards for electronic health care transaction (HIPAA, 1996). Under mode 1 trade, 
cross-border transfer of electronic files raises legal questions about HIPAA adherence 
as well as possible liability concerns   
 
Changes to public policy 
 Many of the policies presented in the American heath care system, while offering 
unrivaled patient protection, hinder the proliferation of cross-border trade in health 
services and deny the potential financial gains intrinsically linked to international 
medical care. With recognition of the cost reductions and care improvements possible 
through the liberalization of increased medical tourism, policy makers, both public and 
private, have the opportunity to reshape health care policies to take advantage of these 
possibilities while preserving patient rights. Global competition has led to significant 
improvements across many industries, such as the automobile industry . As medical 
systems in the developing world continue to improve, global competition in health care 
can accomplish similar results. Several logical changes could be made to the health 
care system in the United States that would open up international medical-based travel 




Readjust State Licensing Laws 
Traditionally, the physicality of medicine has restricted its consumption to a small area, 
easily accessible by both the patient and the physician. Ever-increasing technology and 
the growth of quality health care in developing countries, however, has drastically 
“flattened” the medical world. Prospective patients are more mobile today, which makes 
the global world of health care more accessible. Consequently, patients can choose to 
be seen at home or abroad. In order to facilitate international care, state licensing laws 
should be readjusted to conform to the information age, where locale is less relevant. 
Doctors are now able to communicate with prospective patients and other physicians 
across the globe via video-conferencing and other internet avenues. Medicine is no 
longer a location-centric service. Patients in the United States should be able to receive 
treatment from physicians in other parts of the world. Physicians in Thailand, India, 
Singapore and other countries often hold board certifications in the United States. 
Patients are able to secure quality care from these physicians regardless of their home 
state and should be free to take advantage of cost-savings found in international care 
(Cwiek, 2007). State regulations could conceivably be relaxed to focus on equal 
standards of care instead of rigid licensing programs (Herrick, 2007). 
 
Encourage Cross-border Collaboration 
Increased collaboration among physicians, both foreign and domestic, has the potential 
to facilitate quality increases and offer cost-savings to the American health care system. 
Similar to what is beginning to be seen in Accountable Care Organizations (ACO), 
groups of physicians spanning multiple countries can be held collectively accountable 
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for the quality of care provided to American patients via contractual obligations (Elliot, 
2011). The Stark Laws, however, would have to be revised to allow for increased 
collaboration with international providers (Herrick, 2007; Leibenluft, 2011). Practices 
could streamline care by employing a network of providers and information systems, 
providing timely care specific to the needs of each patient (Elliot, 2011).  
 
Encourage domestic follow up care 
Physicians prefer ongoing relationships, seeing patients from initial consultations 
through follow-up care and release. Patients who have travelled abroad to receive 
medical procedures have returned home to find domestic care givers who refuse to 
provide follow-up care due to liability issues (York, 2008). A framework releasing 
physicians from liability risks after overseeing medical tourists through the post-
operative stage could encourage increased international medical traffic. As medical 
tourism increases, practices specializing in highly tradable procedures will begin to 
recognize the financial benefits linked with providing follow up care for those services 
rendered abroad (Herrick, 2007). 
  
Malpractice in the Underdeveloped World 
 One of the most daunting barriers between the current American health care 
system and extensive international trade in health services is the lack of malpractice 
protection in the international market. Remarkably few cases of malpractice during 
medical tourism abroad have been reported, but those unlucky victims of malpractice 
have few, if any, safeguards or legal means to seek relief. Currently, there is no 
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international legal framework to protect patients in cases of medical malpractice (Mirrer-
Singer, 2007).   
 The only potential defendants in a malpractice suit involving health services 
rendered abroad are 1) the foreign provider or 2) a medical tourism brokerage firm 
located in the United States (Mirrer-Singer, 2007). Such a case would have significant 
legal hurdles, likely insurmountable under current frameworks, and jurisdictional 
requirements in the United States. Potential legal remedies, however feeble, exist and 
merit discussion.  
 If considering a filing a lawsuit against a foreign provider, the plaintiff must 
establish that the court has personal jurisdiction over the nonresident defendant. In 
domestic cases filed against physicians practicing outside the forum state, courts have 
been reluctant to exercise personal jurisdiction over the defendant (Biggs v. Robert 
Thomas, O.D., 1995; Grove v. Mahaswaran, 1997). Plaintiffs can often circumvent this 
problem by filing suit in the home state of the physician. In a case of medical tourism, 
however, action of this sort would be unfruitful as the physician probably operates in a 
country that has no framework for malpractice litigation (Turner, 2007).  Continuing tort 
theory also provides conceivable legal avenues in domestic cases, but minimal merit for 
victims of international malpractice (Mirrer-Singer, 2007). This theory holds that 
physicians may be liable, regardless of location of the forum state relevant to the 
physician’s licensure, if a relationship has been perpetuated between the patient and 




 Filing a lawsuit against a medical tourism intermediary that provided 
arrangements for travel and care provisions to an American patient provides potential 
plaintiffs with more viable options. Unlike foreign physicians, medical travel 
intermediaries are not encumbered by personal jurisdiction problems. Firms 
incorporated in the United States establish its principal place of business in a particular 
state, thus subjecting themselves to that state’s jurisdiction (Mirrer-Singer, 2007). 
Victims of malpractice abroad could potentially invoke theories of corporate negligence 
against intermediaries to pursue damages in the courts. Informed consent also provides 
potential grounds for litigation against medical travel intermediaries, since such entities 
go to great lengths to advertise the quality of international care and even advise 
prospective travelers. If this care proves to be substandard, however, especially in 
cases meriting malpractice, patients could seek to prove intermediaries misrepresented 
to quality of care that they facilitate.  
 Again, while these legal theories provide conceivable avenues for litigation, they 
have never been pursued with success in the international health market (Mirrer-Singer, 
2007). Legal frameworks in developing countries are too primitive and foreign care 




 Trends in cross-border trade in health services continue to rise. More and more 
patients from the United States and other first world countries are beginning to seek 
health care in the international market. Import markets are beginning to recognize the 
vast cost-saving potential of medical tourism, benefits of trade in related industries, and 
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the potential to streamline health care through increased global competition among 
physicians, medical facilities, and insurance providers. A global marketplace in health 
services liberalizes the accessibility of health care in both the developed and developing 
world. In recognition of both the economic and social gains associated with increased 
trade in health services, appropriate steps need to be taken to increase the viability and 
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